comparemela.com

Page 10 - Vaxcyte Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaxcyte Announces Closing of $862 5 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares -February 02, 2024 at 06:40 pm EST

SAN CARLOS, Calif., Feb. 02, 2024 Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases,.

Vaxcyte Announces Closing of $862 5 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

03.02.2024 - SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the .

Director Heath Lukatch Sells 5,000 Shares of Vaxcyte Inc (PCVX)

On January 31, 2024, Heath Lukatch, a Director at Vaxcyte Inc, executed a sale of 5,000 shares of the company's stock.

Director Heath Lukatch Sells 4,000 Shares of Vaxcyte Inc (PCVX)

According to a recent SEC filing, Director Heath Lukatch has sold 4,000 shares of Vaxcyte Inc (NASDAQ:PCVX) on January 29, 2024.

Moody Aldrich Partners LLC Buys 115,505 Shares of Vaxcyte, Inc (NASDAQ:PCVX)

Moody Aldrich Partners LLC Buys 115,505 Shares of Vaxcyte, Inc (NASDAQ:PCVX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.